Hao Cao

2.1k total citations · 1 hit paper
49 papers, 1.5k citations indexed

About

Hao Cao is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Hao Cao has authored 49 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Surgery and 12 papers in Oncology. Recurrent topics in Hao Cao's work include Cancer Immunotherapy and Biomarkers (5 papers), Tissue Engineering and Regenerative Medicine (4 papers) and Peptidase Inhibition and Analysis (4 papers). Hao Cao is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Tissue Engineering and Regenerative Medicine (4 papers) and Peptidase Inhibition and Analysis (4 papers). Hao Cao collaborates with scholars based in China, Australia and United States. Hao Cao's co-authors include Huimin Fan, Jianjun Chen, Xiaohui Zhou, Binbin Cheng, Zhenzhen Zhan, Xu Dong Zhang, Zhongmin Liu, Galina Yurevna Zheleznyakova, Helgi B. Schiöth and Yichang Ren and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Biochemical and Biophysical Research Communications.

In The Last Decade

Hao Cao

47 papers receiving 1.5k citations

Hit Papers

Injectable hydrogel with MSNs/microRNA-21-5p delivery ena... 2021 2026 2022 2024 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Injectable hydrogel with MSNs/microRNA-21-5p delivery enables both immunomodification and enhanced angiogenesis for myocardial infarction therapy in pigs
    2021 194 citations Hao Cao, Yun Dong et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hao Cao China 22 612 268 254 184 155 49 1.5k
Shuhong Zhang China 23 644 1.1× 273 1.0× 373 1.5× 171 0.9× 126 0.8× 89 1.6k
Yulai Zhou China 24 759 1.2× 207 0.8× 204 0.8× 104 0.6× 220 1.4× 69 1.5k
Wendy Lee United States 25 947 1.5× 220 0.8× 485 1.9× 283 1.5× 162 1.0× 56 2.6k
Xiaochun Peng China 23 807 1.3× 321 1.2× 490 1.9× 110 0.6× 226 1.5× 74 1.8k
Jiyoon Kim South Korea 26 858 1.4× 186 0.7× 247 1.0× 205 1.1× 243 1.6× 87 2.1k
Yanting Zhu China 24 882 1.4× 243 0.9× 217 0.9× 115 0.6× 322 2.1× 93 1.8k
Jing Hou China 23 900 1.5× 240 0.9× 227 0.9× 162 0.9× 303 2.0× 44 1.8k
Young Kwan Sung South Korea 27 896 1.5× 190 0.7× 127 0.5× 116 0.6× 270 1.7× 69 2.4k
Hongmei Wang China 23 641 1.0× 370 1.4× 251 1.0× 268 1.5× 434 2.8× 90 1.7k

Countries citing papers authored by Hao Cao

Since Specialization
Citations

This map shows the geographic impact of Hao Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Cao more than expected).

Fields of papers citing papers by Hao Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hao Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Cao. The network helps show where Hao Cao may publish in the future.

Co-authorship network of co-authors of Hao Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Hao Cao. A scholar is included among the top collaborators of Hao Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hao Cao. Hao Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yong, et al.. (2024). Successful surgical treatment of impending paradoxical embolism with pulmonary embolism and myocardial infarction. Journal of Cardiothoracic Surgery. 19(1). 137–137.
2.
Gao, Yang, et al.. (2024). Cerebral Embolism and MINOCA Secondary to Left Atrial Myxoma after Occlusion of Atrial Septal Defect by Amplatzer Occluder: A Case Report. The Heart Surgery Forum. 27(1). E006–E013. 1 indexed citations
3.
Mei, Tianxiao, Hao Cao, Teng Ma, et al.. (2024). 3D Printed Conductive Hydrogel Patch Incorporated with MSC@GO for Efficient Myocardial Infarction Repair. ACS Biomaterials Science & Engineering. 10(4). 2451–2462. 18 indexed citations
4.
Liu, Shuang, Jiaqi Wu, Dongyan Feng, et al.. (2022). Structural and biochemical insights into the association between ERAP1 polymorphism and autoimmune diseases. Biochemical and Biophysical Research Communications. 632. 189–194. 4 indexed citations
5.
Cao, Hao, et al.. (2022). Combination therapy of hydrogel and stem cells for diabetic wound healing. World Journal of Diabetes. 13(11). 949–961. 26 indexed citations
6.
Peng, Xiaopeng, Ling Li, Jingxuan Chen, et al.. (2022). Discovery of Novel Histone Deacetylase 6 (HDAC6) Inhibitors with Enhanced Antitumor Immunity of Anti-PD-L1 Immunotherapy in Melanoma. Journal of Medicinal Chemistry. 65(3). 2434–2457. 35 indexed citations
7.
Cao, Hao, Binbin Cheng, Ting Liu, & Jianjun Chen. (2021). Synthesis and pharmacological evaluation of novel resorcinol biphenyl ether analogs as small molecule inhibitors of PD-1/PD-L1 with benign toxicity profiles for cancer treatment. Biochemical Pharmacology. 188. 114522–114522. 17 indexed citations
8.
Cheng, Binbin, et al.. (2020). Discovery of novel CA-4 analogs as dual inhibitors of tubulin polymerization and PD-1/PD-L1 interaction for cancer treatment. European Journal of Medicinal Chemistry. 213. 113058–113058. 28 indexed citations
9.
Cheng, Binbin, Wei Wang, Xiaoge Niu, et al.. (2020). Discovery of Novel and Highly Potent Resorcinol Dibenzyl Ether-Based PD-1/PD-L1 Inhibitors with Improved Drug-like and Pharmacokinetic Properties for Cancer Treatment. Journal of Medicinal Chemistry. 63(24). 15946–15959. 43 indexed citations
10.
Cao, Hao, Yun Dong, Lei Gao, et al.. (2020). Therapeutic silencing miR-146b-5p improves cardiac remodeling in a porcine model of myocardial infarction by modulating the wound reparative phenotype. Protein & Cell. 12(3). 194–212. 40 indexed citations
11.
Cheng, Binbin, Yichang Ren, Hao Cao, & Jianjun Chen. (2020). Discovery of novel resorcinol diphenyl ether-based PROTAC-like molecules as dual inhibitors and degraders of PD-L1. European Journal of Medicinal Chemistry. 199. 112377–112377. 87 indexed citations
12.
Cao, Hao, Ling Li, Liming Zeng, et al.. (2019). Recent progress in histone methyltransferase (G9a) inhibitors as anticancer agents. European Journal of Medicinal Chemistry. 179. 537–546. 81 indexed citations
13.
Liu, Xingguang, Hao Cao, Jian Li, et al.. (2017). Autophagy induced by DAMPs facilitates the inflammation response in lungs undergoing ischemia-reperfusion injury through promoting TRAF6 ubiquitination. Cell Death and Differentiation. 24(4). 683–693. 86 indexed citations
14.
Cao, Hao, Kaili Nie, Chengcheng Li, et al.. (2017). Rational design of substrate binding pockets in polyphosphate kinase for use in cost-effective ATP-dependent cascade reactions. Applied Microbiology and Biotechnology. 101(13). 5325–5332. 18 indexed citations
15.
Cao, Hao, et al.. (2015). MicroRNA screening and functional study of obliterative bronchiolitis in a rat model simulating lung transplantation. Genetics and Molecular Research. 14(4). 19309–19316. 6 indexed citations
16.
Zhou, Xiaohui, Jiayou Tang, Hao Cao, Huimin Fan, & Bin Li. (2015). Tissue resident regulatory T cells: novel therapeutic targets for human disease. Cellular and Molecular Immunology. 12(5). 543–552. 46 indexed citations
17.
18.
Zhu, Changtai, Hao Cao, Judong Luo, et al.. (2013). Meta-Analysis of the Clinical Value of Danshen Injection and Huangqi Injection in Liver Cirrhosis. Evidence-based Complementary and Alternative Medicine. 2013. 1–8. 15 indexed citations
19.
20.
Cao, Hao, Qin Lan, Xiaohui Zhou, et al.. (2010). Anti-IL-23 antibody blockade of IL-23/IL-17 pathway attenuates airway obliteration in rat orthotopic tracheal transplantation. International Immunopharmacology. 11(5). 569–575. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shuhong Zhang Breakdown of academic impact, for papers by Yulai Zhou Breakdown of academic impact, for papers by Wendy Lee Breakdown of academic impact, for papers by Xiaochun Peng Breakdown of academic impact, for papers by Jiyoon Kim Breakdown of academic impact, for papers by Yanting Zhu Breakdown of academic impact, for papers by Jing Hou Breakdown of academic impact, for papers by Young Kwan Sung Breakdown of academic impact, for papers by Hongmei Wang
Rankless by CCL
2026